198 related articles for article (PubMed ID: 30515906)
1. Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Yang J; Wang B; Chen H; Chen X; Li J; Chen Y; Yuan D; Zheng S
Cell Prolif; 2019 Mar; 52(2):e12560. PubMed ID: 30515906
[TBL] [Abstract][Full Text] [Related]
2. Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
Zheng Y; Pei Y; Yang L; Zeng Z; Wang J; Xie G; Wang L; Yuan J
Int J Biol Sci; 2020; 16(16):3221-3230. PubMed ID: 33162827
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
[TBL] [Abstract][Full Text] [Related]
4. MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.
Wang HF; Wu JH; Gai JW; Yang SQ; Ma QT; Ma HS; Feng Q
Gene; 2018 Dec; 679():314-319. PubMed ID: 30218751
[TBL] [Abstract][Full Text] [Related]
5. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
Zhang L; Wang CZ; Ma M; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
Yan T; Ye XX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ASPM and TEF Gene Expressions as Potential Biomarkers for Bladder Cancer.
Saleh AA; Gohar SF; Hemida AS; Elgharbawy M; Soliman SE
Biochem Genet; 2020 Jun; 58(3):490-507. PubMed ID: 32274607
[TBL] [Abstract][Full Text] [Related]
8. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
9. GINS1 promotes the initiation and progression of bladder cancer by activating the AKT/mTOR/c-Myc signaling pathway.
Fu Q; Zheng H; Wang X; Tang F; Yu H; Wang H; Wan Z; Zheng Z; Yang Z; Liu T; Peng J
Exp Cell Res; 2024 Jul; 440(1):114125. PubMed ID: 38880324
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
11. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
Li Y; Zhang X; Zhou X; Zhang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262971
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
13. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
14. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of MTHFD2 is associated with PD‑L1 activation in bladder cancer via the PI3K/AKT pathway.
Deng X; Liu X; Hu B; Liu J; Fu B; Zhang W
Int J Mol Med; 2023 Feb; 51(2):. PubMed ID: 36601741
[TBL] [Abstract][Full Text] [Related]
16. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
Wang X; Lyu J; Ji A; Zhang Q; Liao G
Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
[TBL] [Abstract][Full Text] [Related]
17. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
19. miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
Yang J; Yuan D; Li J; Zheng S; Wang B
Tumour Biol; 2016 Apr; 37(4):4331-41. PubMed ID: 26494000
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.
Ye W; Chen C; Gao Y; Zheng ZS; Xu Y; Yun M; Weng HW; Xie D; Ye S; Zhang JX
Cell Death Dis; 2017 Feb; 8(2):e2581. PubMed ID: 28151475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
